US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Concho Resources

65.60

0.0000

Volume:- -

Turnover:- -

Market Cap:12.76B

PE:-1.26

High:65.60

Open:65.60

Low:65.60

Close:65.60

52wk High:90.52

52wk Low:33.13

Shares:194.51M

Float Shares:192.49M

Volume Ratio:- -

T/O Rate:- -

Dividend:0.73

Dividend Rate:1.11%

EPS(TTM):-52.2669

EPS(LYR):-3.5480

ROE:-77.91%

ROA:-30.69%

PB:1.64

PE(LYR):-18.49

Loading ...

Overview Company News Filings

Hong Kong Stock Concept Tracking | Strong Performance Growth in Innovative Drug Sector, Upstream CXO Industry Adjustments Largely Completed (With Concept Stocks)

China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs

Haina Pharma's Shift to Hong Kong IPO: CXO Dependence, Cash Flow Woes, and Volatile Major Clients

Core Lithium (ASX:CXO): Assessing Valuation After Finniss Project Overhaul and Upgraded Ore Reserves

Simply Wall St.

Why Core Lithium (ASX:CXO) Is Up 26.7% After Upgrading Finniss Ore Reserves and Cutting Costs

Simply Wall St.

IPO Preview: Can Haina Pharma's "CXO + Proprietary Pipeline" Model Shine in Hong Kong?

Haina Pharma's HK IPO: Declining Revenue & Net Profit in H1, Heavy Reliance on CXO Services Raises Sustainability Concerns

CMB International: CXO Sector Performance May Recover in H2, Favors SINO BIOPHARM and WUXI XDC

GF Securities Strategy: Current Industry Positions and Preliminary 2026 Sector Allocation Outlook

WuXi AppTec Sells CRO Business for 2.8 Billion Yuan, Signaling Structural Shift in CXO Industry

Core Lithium (ASX:CXO) Raises Fresh Capital—Will This New War Chest Accelerate Growth Plans?

Simply Wall St.

China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others

JP Morgan: Maintains WuXi AppTec (02359) as Top CXO Pick, Keeps "Overweight" Rating

Why Core Lithium (ASX:CXO) Is Up 9.5% After Sharply Narrowing Its Annual Net Loss

Simply Wall St.

CXO Market Recovery Underway as CDMO Companies Expand into Emerging Sectors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CXO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CXO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","market":"US","secType":"STK","nameCN":"Concho Resources","latestPrice":65.6,"timestamp":1610744400000,"preClose":65.6,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":192489259,"shares":194506801,"eps":-52.266872,"marketStatus":"Delisted","change":0,"latestTime":"01-15 16:00:00 EST","open":65.6,"high":65.6,"low":65.6,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-52.266872,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774339200000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1186113600000,"exchange":"NYSE","adjPreClose":65.6,"dividendRate":0.011052,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CXO\",,,,,undefined,":{"symbol":"CXO","floatShares":192489259,"roa":"-30.69%","roe":"-77.91%","lyrEps":-3.548023,"shares":194506801,"dividePrice":0.725,"high":65.6,"amplitude":0,"preClose":65.6,"low":65.6,"week52Low":33.13,"pbRate":"1.64","week52High":90.52,"institutionHeld":0,"latestPrice":65.6,"eps":-52.266872,"divideRate":0.011052,"volume":0,"delay":0,"ttmEps":-52.266872,"open":65.6},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CXO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-19","symbol":"CXO","reason":null,"defaultRemindTime":1611066600000,"announcedDate":"2021-01-14","type":"delisting","dateTimestamp":1611032400000},{"market":"US","date":"2020-11-05","symbol":"CXO","amount":0.2,"defaultRemindTime":1604586600000,"name":"康休","payableDate":"2020-11-06","currency":"USD","type":"dividend","dateTimestamp":1604552400000},{"market":"US","date":"2020-10-27","symbol":"CXO","fiscalQuarterEnding":"2020/09","expectedEps":1.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":1.43},{"market":"US","date":"2020-08-06","symbol":"CXO","amount":0.2,"defaultRemindTime":1596720600000,"name":"康休","payableDate":"2020-08-07","currency":"USD","type":"dividend","dateTimestamp":1596686400000},{"market":"US","date":"2020-07-29","symbol":"CXO","fiscalQuarterEnding":"2020/06","expectedEps":0.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1595995200000,"reportTimeType":"post","actualEps":1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CXO\",market:\"US\",,,undefined,":[{"executeDate":"2019-02-28","recordDate":null,"paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-05-09","recordDate":"2019-05-10","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-08-08","recordDate":"2019-08-09","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2019-11-07","recordDate":"2019-11-08","paymentDate":null,"value":0.125,"currency":"USD"},{"executeDate":"2020-02-27","recordDate":"2020-02-28","paymentDate":null,"value":0.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CXO\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CXO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CXO","date":"2021-01-15","current":-1.255097,"percent":0.244996,"low":-22.831021,"twenty":-14.937462,"median":17.448879,"eighty":43.624979,"high":142.858816,"avg":25.025998,"sd":38.430736,"marketCap":13577273687},"quantilePoints":[],"updateTime":1774332095322},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CXO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1179782588","title":"Hong Kong Stock Concept Tracking | Strong Performance Growth in Innovative Drug Sector, Upstream CXO Industry Adjustments Largely Completed (With Concept Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1179782588","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179782588?lang=en_us&edition=fundamental","pubTime":"2025-11-24 08:24","pubTimestamp":1763943884,"startTime":"0","endTime":"0","summary":"Wind data shows that among 29 listed companies in the A-share CXO sector, 20 reported year-on-year revenue growth for the first three quarters. The performance of innovative drug companies has been...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU1046422090.SGD","LU0708995583.HKD","BK1191","LU0516423091.SGD","LU0516422366.SGD","LU0140636845.USD","LU0320764599.SGD","LU0326950275.SGD","LU0327786744.USD","BK1161","BK1583","LU0348735423.USD","06978","LU2045819591.USD","LU0516422952.EUR","LU0856984785.SGD","SG9999002463.SGD","LU0052750758.USD","LU1720050803.USD","LU1880383366.USD","LU3063872942.SGD","02269","LU0043850808.USD","LU0417516902.SGD","LU0516422440.USD","LU1688375341.USD","LU2039709279.SGD","CXO","LU0823426308.USD","LU0456827905.SGD","LU0456846285.SGD","LU0516423174.USD","LU0051755006.USD","LU0307460666.USD","LU0359201612.USD","LU0359202008.SGD","IE00B0JY6N72.USD","LU0572944931.SGD","LU0819121731.USD","LU1794554557.SGD","LU0039217434.USD","LU0823426480.USD","LU2125910500.SGD","LU0181495838.USD","02359","LU1242518857.USD","LU1242518931.SGD","159992","BK1589","BK1576","SG9999002562.SGD","LU0348825331.USD","LU2242644610.SGD","06821","LU0588546209.SGD","BK1574","BK1610","LU0417516738.SGD","BK1141","LU0979878070.USD"],"gpt_icon":0},{"id":"1118534015","title":"China Securities Co., Ltd.: CXO Sector Adjustment Nears Completion, Focus on CDMO Firms with Strong Overseas Expansion and Leading Clinical CROs","url":"https://stock-news.laohu8.com/highlight/detail?id=1118534015","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118534015?lang=en_us&edition=fundamental","pubTime":"2025-11-24 07:42","pubTimestamp":1763941341,"startTime":"0","endTime":"0","summary":"According to a research report by China Securities Co., Ltd., the innovative drug sector exhibits three major trends: deepening internationalization (2.0 phase), with 2025 license-out deals reaching...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO","601066","CDMO","BK4139","BK0276"],"gpt_icon":0},{"id":"1116189617","title":"Haina Pharma's Shift to Hong Kong IPO: CXO Dependence, Cash Flow Woes, and Volatile Major Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=1116189617","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116189617?lang=en_us&edition=fundamental","pubTime":"2025-11-23 16:40","pubTimestamp":1763887244,"startTime":"0","endTime":"0","summary":"After failing in its attempt to list on the ChiNext board and an unsuccessful acquisition by Chengdu Pioneer (688222.SH), Nanjing Haina Pharmaceutical Technology Co., Ltd. (hereinafter referred to as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1515","CXO","BK1574","159938","159399","09939"],"gpt_icon":0},{"id":"2583638001","title":"Core Lithium (ASX:CXO): Assessing Valuation After Finniss Project Overhaul and Upgraded Ore Reserves","url":"https://stock-news.laohu8.com/highlight/detail?id=2583638001","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583638001?lang=en_us&edition=fundamental","pubTime":"2025-11-15 05:39","pubTimestamp":1763156368,"startTime":"0","endTime":"0","summary":"Core Lithium (ASX:CXO) climbed to a 52-week high after announcing a revised reopening plan for its Finniss Project. The new plan lowers pre-production costs and increases the Grants deposit ore reserve estimate by 33%.\nSee our latest analysis for Core Lithium.\nThis rally caps off a stunning stretch for Core Lithium, with a 1-day share price return of 5.26% and 37.93% over the past week. This reflects renewed investor confidence after the Finniss Project update. Momentum has accelerated...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-assessing-valuation-after-finniss-projec","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-assessing-valuation-after-finniss-projec","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CXO.AU","PLS.AU","CXO"],"gpt_icon":0},{"id":"2583561324","title":"Why Core Lithium (ASX:CXO) Is Up 26.7% After Upgrading Finniss Ore Reserves and Cutting Costs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583561324","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583561324?lang=en_us&edition=fundamental","pubTime":"2025-11-13 17:20","pubTimestamp":1763025616,"startTime":"0","endTime":"0","summary":"Core Lithium recently announced an updated reopening plan for the Finniss Project, deferring the transition to underground mining and cutting pre-production costs by A$35 million to A$45 million, while also increasing the ore reserve estimate for the Grants deposit by 33%.\nThis development enhances the project's appeal for funding partners and aligns with stronger global demand for battery-grade lithium, supported by recent strength in lithium prices.\nWe'll explore how the ore reserve...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-267-after-upgrading-finniss-or","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-267-after-upgrading-finniss-or","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PLS.AU","BK7504","CXO","BK7507","AI","CXO.AU","BK7095"],"gpt_icon":0},{"id":"1173746546","title":"IPO Preview: Can Haina Pharma's \"CXO + Proprietary Pipeline\" Model Shine in Hong Kong?","url":"https://stock-news.laohu8.com/highlight/detail?id=1173746546","media":"Stock News","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173746546?lang=en_us&edition=fundamental","pubTime":"2025-11-13 16:30","pubTimestamp":1763022626,"startTime":"0","endTime":"0","summary":"Nanjing Haina Pharmaceutical Technology Co., Ltd. (Haina Pharma) has submitted its IPO application to the Hong Kong Stock Exchange, with China International Capital Corporation (CICC) as its sole...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","CXO","BK1574","159938","09939"],"gpt_icon":0},{"id":"1116581182","title":"Haina Pharma's HK IPO: Declining Revenue & Net Profit in H1, Heavy Reliance on CXO Services Raises Sustainability Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=1116581182","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116581182?lang=en_us&edition=fundamental","pubTime":"2025-11-12 16:11","pubTimestamp":1762935065,"startTime":"0","endTime":"0","summary":"Nanjing Haina Pharmaceutical Technology Co., Ltd. officially submitted its main board listing application to the Hong Kong Stock Exchange on November 7, 2025. This marks the company's third attempt...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159776","CXO"],"gpt_icon":0},{"id":"1158115340","title":"CMB International: CXO Sector Performance May Recover in H2, Favors SINO BIOPHARM and WUXI XDC","url":"https://stock-news.laohu8.com/highlight/detail?id=1158115340","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158115340?lang=en_us&edition=fundamental","pubTime":"2025-11-11 14:30","pubTimestamp":1762842622,"startTime":"0","endTime":"0","summary":"CMB International released a research report stating that the MSCI China Healthcare Index has surged 59.5% year-to-date, outperforming the MSCI China Index by 24%. However, the healthcare sector has...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","IE00BZ08YT58.USD","IE00BZ08YR35.GBP","BK1521","SG9999014674.SGD","02268","01177","LU2488822045.USD","BK1515","BK1589","CXO","HK0000165453.HKD","IE00BZ08YS42.EUR","BK1191"],"gpt_icon":0},{"id":"1103413869","title":"GF Securities Strategy: Current Industry Positions and Preliminary 2026 Sector Allocation Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=1103413869","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103413869?lang=en_us&edition=fundamental","pubTime":"2025-11-09 15:30","pubTimestamp":1762673447,"startTime":"0","endTime":"0","summary":"As we enter early November, a key task is to outline next year’s sector allocation strategy to facilitate early research. Our framework for industry comparison revolves around four stages:...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TTM","BK4099","BK4523","CXO","159982","399300"],"gpt_icon":0},{"id":"1172684711","title":"WuXi AppTec Sells CRO Business for 2.8 Billion Yuan, Signaling Structural Shift in CXO Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1172684711","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172684711?lang=en_us&edition=fundamental","pubTime":"2025-10-27 21:10","pubTimestamp":1761570658,"startTime":"0","endTime":"0","summary":"WuXi AppTec has announced the sale of its clinical research assets for 2.8 billion yuan, with Hillhouse Capital as the buyer. The deal, disclosed on October 26, involves WuXi AppTec’s wholly-owned...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CXO"],"gpt_icon":0},{"id":"2576895708","title":"Core Lithium (ASX:CXO) Raises Fresh Capital—Will This New War Chest Accelerate Growth Plans?","url":"https://stock-news.laohu8.com/highlight/detail?id=2576895708","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576895708?lang=en_us&edition=fundamental","pubTime":"2025-10-20 09:10","pubTimestamp":1760922630,"startTime":"0","endTime":"0","summary":"Core Lithium Ltd recently completed an institutional placement by issuing 198,125,292 ordinary shares at A$0.105 per share to institutional and professional investors.\nThis capital raise is part of Core Lithium's plan to reinforce its financial footing and create opportunities for operational growth in the lithium sector.\nWe will explore how this equity placement may reshape Core Lithium's investment narrative, particularly its impact on available growth capital.\nAI is about to change...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-raises-fresh-capitalwill-this-new-war-ch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/core-lithium-asxcxo-raises-fresh-capitalwill-this-new-war-ch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4551","CXO.AU","BK7504","BK4528","BK7095","BK4543","BK7507","BK4588","BK4587","CXO","AAQC","BK4585","PLS.AU","BK4023","AI"],"gpt_icon":0},{"id":"1171805526","title":"China Merchants International: Limited Impact Expected from US Tariffs on Innovative Drugs for CXO Companies, Recommends Buying 3SBIO (01530) and Others","url":"https://stock-news.laohu8.com/highlight/detail?id=1171805526","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171805526?lang=en_us&edition=fundamental","pubTime":"2025-09-30 16:23","pubTimestamp":1759220589,"startTime":"0","endTime":"0","summary":"China Merchants Securities International released a research report stating that Sino-US innovation cooperation is expected to continue, with domestic innovation R&D demand in China showing signs of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1515","02273","IE00BZ08YR35.GBP","LU2328871848.SGD","BK1207","01801","BK1521","BK1161","IE00BZ08YT58.USD","LU2097828557.USD","LU0502904849.HKD","SG9999014674.SGD","LU2242644610.SGD","LU0455707207.USD","02367","BK1583","LU2097828805.USD","LU2097828714.EUR","BK1219","BK1191","159992","LU2097828631.EUR","CXO","IE00BZ08YS42.EUR","06978","BK1589","SG9999004311.SGD","01530","01177","LU2097828474.EUR","LU2488822045.USD","BK1574","BK1141","02268","LU1969619763.USD"],"gpt_icon":0},{"id":"1169841580","title":"JP Morgan: Maintains WuXi AppTec (02359) as Top CXO Pick, Keeps \"Overweight\" Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1169841580","media":"Stock News","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169841580?lang=en_us&edition=fundamental","pubTime":"2025-09-29 13:58","pubTimestamp":1759125530,"startTime":"0","endTime":"0","summary":"JP Morgan released a research report stating that it continues to list WuXi AppTec (02359) as its top pick in China's CXO industry. The firm noted that the company is China's largest contract...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603259","BK1583","BK1576","LU2488822045.USD","LU1997245177.USD","LU2125910500.SGD","BK1141","LU1934453819.USD","LU0052750758.USD","LU1979443071.USD","LU1969619763.USD","LU0320764599.SGD","02359","LU1808992512.USD","LU2242644610.SGD","LU0708995583.HKD","LU1046422090.SGD","LU1997244956.HKD","LU0456842615.SGD","LU2495084118.USD","LU1997245094.SGD","LU2328871848.SGD","BK0216","CXO","LU2045819591.USD"],"gpt_icon":0},{"id":"2570191468","title":"Why Core Lithium (ASX:CXO) Is Up 9.5% After Sharply Narrowing Its Annual Net Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2570191468","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570191468?lang=en_us&edition=fundamental","pubTime":"2025-09-28 05:28","pubTimestamp":1759008509,"startTime":"0","endTime":"0","summary":"Core Lithium Ltd recently announced its full year earnings result for the period ended June 30, 2025, reporting a net loss of A$23.37 million, down from A$207.01 million a year earlier.\nThis sharp reduction in annual net loss reflects a marked improvement in the company’s financial performance compared to the previous year.\nWe'll explore how Core Lithium’s significantly narrowed annual net loss could shape the outlook for its earnings recovery story.\nWe've found 19 US stocks that are...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2052000-choice1-main-header/1585186836557"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-95-after-sharply-narrowing-its","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-cxo/core-lithium-shares/news/why-core-lithium-asxcxo-is-up-95-after-sharply-narrowing-its","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7507","BK7504","CXO.AU","PLS.AU","BK7095","CXO"],"gpt_icon":0},{"id":"1187585376","title":"CXO Market Recovery Underway as CDMO Companies Expand into Emerging Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1187585376","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187585376?lang=en_us&edition=fundamental","pubTime":"2025-09-26 14:12","pubTimestamp":1758867170,"startTime":"0","endTime":"0","summary":"According to a research report, based on statistics from Pharmcube, domestic innovative drug financing reached $7.75 billion in the first eight months of 2025, representing a year-over-year increase...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422952.EUR","BK1521","LU0307460666.USD","LU0708995583.HKD","LU0320764599.SGD","BK1610","LU1242518931.SGD","BK1141","LU0516423174.USD","IE00B0JY6N72.USD","LU1046422090.SGD","LU1242518857.USD","LU1688375341.USD","LU0039217434.USD","LU0140636845.USD","BK0276","LU2045819591.USD","CXO","LU0516422440.USD","LU0327786744.USD","601059","LU0051755006.USD","LU0823426480.USD","LU0516422366.SGD","LU1794554557.SGD","BK1583","LU0572944931.SGD","LU2125910500.SGD","LU0516423091.SGD","BK1191","LU0052750758.USD","LU0417516902.SGD","LU0856984785.SGD","LU1720050803.USD","LU0043850808.USD","LU0456827905.SGD","LU0348735423.USD","LU0588546209.SGD","LU2488822045.USD","LU0359202008.SGD","BK1576","02269","SG9999002463.SGD","LU0181495838.USD","SG9999002562.SGD","03759","CDMO","LU0979878070.USD","02359","LU1880383366.USD","02268","06821","LU0456846285.SGD","LU2039709279.SGD","LU2242644610.SGD","LU0359201612.USD","SG9999014674.SGD","LU0823426308.USD","BK1589","LU0348825331.USD","LU0819121731.USD","LU0326950275.SGD","BK4139","LU0417516738.SGD","06127"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":35,"code":"91000000","status":"200"}]}}